ProQR Therapeutics (PRQR) Revenue (2012 - 2026)
ProQR Therapeutics (PRQR) posted Revenue of $2.4 million for Q1 2026, down 56.38% sequentially from $5.5 million in Q4 2025, and down 49.93% YoY from $4.8 million in Q1 2025.
ProQR Therapeutics (PRQR) Revenue (2012 - 2026) Analysis & Trends
ProQR Therapeutics has reported Revenue for 15 years, with the latest figure at $2.4 million in Q1 2026.
- Quarterly Revenue fell 49.93% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.5 million (down 23.76% YoY) and the FY2025 annual result came in at $18.5 million, down 8.35% from the prior year.
- Revenue eased to $2.4 million in Q1 2026 per PRQR's latest filing, from $5.5 million in the prior quarter.
- Over five years, Revenue peaked at $6.8 million in Q2 2024 and troughed at $703038.9 in Q1 2023.
- A 5-year average of $3.0 million and a median of $3.4 million in 2025 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2024: Revenue tumbled 91.31% in 2022, then surged 587.63% in 2024.
- Over 5 years, Revenue stood at $734578.1 in 2022, then soared by 381.01% to $3.5 million in 2023, then jumped by 30.26% to $4.6 million in 2024, then advanced by 18.57% to $5.5 million in 2025, then sank by 56.38% to $2.4 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $2.4 million, $5.5 million, and $3.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - | 2.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.38 Mn |
| Dec 31, 2025 | 5.46 Mn |
| Sep 30, 2025 | 3.37 Mn |
| Jun 30, 2025 | 4.32 Mn |
| Mar 31, 2025 | 4.75 Mn |
| Dec 31, 2024 | 4.60 Mn |
| Sep 30, 2024 | 4.22 Mn |
| Jun 30, 2024 | 6.79 Mn |
| Mar 31, 2024 | 4.83 Mn |
| Dec 31, 2023 | 3.53 Mn |
| Sep 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 703,038.89 |
| Dec 31, 2022 | 734,578.10 |
| Sep 30, 2022 | 820,735.30 |
| Jun 30, 2022 | 992,362.72 |
| Mar 31, 2022 | 1.27 Mn |
| Dec 31, 2021 | 273,409.06 |
| Sep 30, 2021 | 1.03 Mn |
| Jun 30, 2021 | 292,637.96 |